Paolo Gallo | Medicine and Health Sciences | Best Paper Award

Published on by Innovation Technologist

Best Paper Award

Paolo Gallo
Bio-Medico Campus University Hospital, Italy

                     Paolo Gallo
Affiliation Bio-Medico Campus University Hospital
Country Italy
Scopus ID 7101785311
Documents 95
Citations 1,878
h-index 25
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-8292-1134

The Best Paper Award recognizes scholarly work that contributes to research development, scientific understanding, and evidence-informed practice. This profile presents Paolo Gallo’s reported bibliometric indicators and selected publications concerning muscle assessment, sarcopenia, and prognostication in chronic liver disease. The recognition is associated with the Global Innovation Technologist Awards and the subject area of Medicine and Health Sciences. Publication details and identifiers provide pathways for readers to examine the underlying research.

Abstract

This academic recognition profile highlights research addressing muscle strength, body composition assessment, and clinical outcomes in chronic liver disease. The selected publications examine potential approaches to identifying sarcopenia and evaluating its prognostic significance in patients with cirrhosis and hepatocellular carcinoma. These topics connect clinical measurement with risk assessment and patient management. The profile combines the supplied publication records with reported citation indicators; it does not constitute an independent audit of bibliometric databases or a formal clinical evidence review.

Keywords

Best Paper Award; Paolo Gallo; Medicine and Health Sciences; hepatology; liver cirrhosis; hepatocellular carcinoma; sarcopenia; muscle strength; ultrasonography; bioelectrical impedance analysis; clinical prognostication; research impact.

Introduction

Chronic liver disease can be accompanied by muscle loss and reduced physical strength, factors that may influence clinical outcomes. Reliable screening and prognostic methods are therefore relevant to hepatology research. Ultrasound-based assessment and bioelectrical impedance analysis offer approaches to evaluating body composition, while investigations of muscle strength may help clarify associations with mortality. The supplied publications provide a focused view of these research questions. [1] [2]

Research Profile

The supplied profile identifies Paolo Gallo with Bio-Medico Campus University Hospital in Italy. Reported metrics include 95 documents, 1,878 citations, and an h-index of 25. These indicators describe aspects of publication output and citation activity, but they do not independently establish methodological quality, clinical effectiveness, or the contribution of individual studies. The Scopus author identifier and ORCID provide routes for checking profile information. [3]

Research Contributions

The selected work addresses three connected areas of investigation:

  • Evaluating the relationship between low muscle strength and mortality among patients with liver cirrhosis and hepatocellular carcinoma.
  • Comparing ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.
  • Reviewing ultrasound-based skeletal muscle assessment for prognostication in cirrhosis.

Together, these topics illustrate the importance of measurable clinical indicators and the evaluation of assessment methods in liver disease research. [1] [2] [4]

Publications

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” Internal and Emergency Medicine, 16 October 2026. [1]
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” Digestive and Liver Disease, October 2026. [2]
  3. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” Liver International, October 2026. [4]

Research Impact

The reported citation count and h-index suggest that the researcher’s publications have accumulated scholarly citations. Their interpretation requires consideration of publication dates, field-specific citation practices, authorship, and database coverage. The selected research themes have potential relevance to clinical assessment and future studies of muscle health in liver disease; practical implications should be determined from the full articles and supporting evidence.

Award Suitability

The Best Paper Award profile aligns with scholarly work in Medicine and Health Sciences through its focus on clinically relevant research questions and assessment methods. The listed publications and bibliometric indicators offer context for evaluating research activity. Final award decisions and claims of formal selection should be confirmed against official award records; this page does not independently verify an award outcome.

Conclusion

Paolo Gallo’s supplied research profile combines established bibliometric indicators with publications addressing sarcopenia, muscle assessment, and outcomes in chronic liver disease. These subjects represent a clinically relevant area of investigation within Medicine and Health Sciences. Author identifiers and DOI links enable further verification of the profile and publication records.

References

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” (2026). Internal and Emergency Medicine.
    https://doi.org/10.1007/s11739-026-04548-y
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” (2026). Digestive and Liver Disease.
    https://doi.org/10.1016/j.dld.2026.10.009
  3. Elsevier. (n.d.). Scopus author details: Paolo Gallo, Author ID 7101785311. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7101785311
  4. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” (2026). Liver International.
    https://doi.org/10.1111/liv.70891
  5. ORCID. (n.d.). Paolo Gallo researcher identifier.
    https://orcid.org/0000-0001-8292-1134
  6. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mahdi Ahmed | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mahdi Ahmed
University of Liverpool, United Kingdom

                  Mahdi Ahmed
Affiliation University of Liverpool
Country United Kingdom
Documents 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0009-0003-2130-2243

The Innovative Research Award profile presents the supplied scholarly information for Mahdi Ahmed, affiliated with the University of Liverpool in the United Kingdom. Associated publication details cover vaccine nanotechnology and cardiovascular mortality research. These subjects connect biomedical investigation with public health priorities, disease prevention and the interpretation of population-level health outcomes. Publication metadata provides a starting point for examining research themes, while independent author-profile verification is necessary to establish attribution and bibliometric performance. [1] [2]

Abstract

This article outlines the supplied research profile and two publications relevant to medicine and health sciences. One examines nanotechnology-enabled vaccines for major infectious diseases, emphasizing translational evidence and implementation in the Global South. The other investigates cardiac arrest and cardiomyopathy-related mortality trends and disparities in the United States from 1999 to 2025. Together, these topics illustrate distinct approaches to health research: developing vaccine technologies and analyzing mortality patterns. The available information does not independently establish authorship, citation totals or award outcomes. [1] [2]

Keywords

Innovative research; medicine and health sciences; nanotechnology-enabled vaccines; infectious diseases; cardiovascular mortality; public health; translational research; health disparities; research evaluation.

Introduction

Biomedical innovation addresses challenges ranging from infectious disease prevention to the assessment of cardiovascular outcomes. Research in these areas may inform vaccine development, health policy and future investigations, although practical benefits depend on the strength of the evidence and subsequent validation. The supplied publications provide a basis for describing these research themes without assuming unverified individual contributions. [1] [2]

Research Profile

The supplied profile identifies Mahdi Ahmed with the University of Liverpool and the United Kingdom. The stated subject area is Medicine and Health Sciences, and the provided ORCID identifier offers a route for checking researcher identity and associated records. Scopus author identification, verified citation totals and h-index information remain unavailable and should be added only after checking authoritative databases.

Research Contributions

The vaccine-focused publication addresses nanotechnology-enabled approaches for malaria, tuberculosis, HIV and dengue, with attention to translational evidence and implementation in the Global South. The cardiovascular study concerns mortality patterns associated with cardiac arrest and cardiomyopathy, including temporal trends and disparities in the United States. These topics represent complementary research priorities, but detailed methods, findings and individual author contributions require review of the full articles. [1] [2]

Publications

  1. Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. Nanomaterials, published 20 October 2026. [1]
  2. Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. ASIDE Cardiovascular, published 3 April 2026. [2]

Research Impact

Potential relevance includes informing research on vaccine delivery and infectious disease prevention, alongside improving understanding of cardiovascular mortality and population disparities. Actual impact should be assessed through verified citations, methodological quality, independent uptake and evidence of clinical or policy application. No citation count or h-index is asserted here because these metrics were not supplied.

Award Suitability

The supplied topics align broadly with the Global Innovation Technologist Awards’ emphasis on research and innovation. A fair assessment for an Innovative Research Award should examine originality, publication quality, methodological rigor, documented contribution and potential societal value. The available metadata supports a preliminary subject-based description, not a confirmed award decision or independently verified evaluation of the named researcher.

Conclusion

The two supplied publications address important questions in infectious disease prevention and cardiovascular public health. Their themes provide a useful starting point for reviewing biomedical research activity. Confirming researcher attribution and assessing individual achievement require verified author records, full-text analysis and reliable bibliometric evidence.

References

  1. Nanomaterials. (2026). Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. DOI: 10.3390/nano16201326.
    https://doi.org/10.3390/nano16201326
  2. ASIDE Cardiovascular. (2026). Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. DOI: 10.71079/ASIDE.CV.040326320.
    https://doi.org/10.71079/ASIDE.CV.040326320
  3. ORCID. (n.d.). Mahdi Ahmed researcher identifier and public profile.
    https://orcid.org/0009-0003-2130-2243
  4. University of Liverpool. (n.d.). Official institutional website.
  5. Elsevier. (n.d.). Scopus abstract and citation database. Researcher metrics and author attribution should be verified against the relevant author record.
  6. Global Innovation Technologist Awards. (n.d.). Official award website and programme information.
    innovationtechnologist.com